Cargando…

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status

Detalles Bibliográficos
Autores principales:	Flanagan, JM, Kugler, S, Waddell, N, Johnstone, CN, Marsh, A, Henderson, S, Simpson, P, da Silva, L, Khanna, K, Lakhani, S, Boshoff, C, Chenevix-Trench, G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875560/ http://dx.doi.org/10.1186/bcr2495

Ejemplares similares

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Exploring the cancer methylome
por: Berman, Benjamin P, et al.
Publicado: (2012)

The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes
por: Johnson, Julie K, et al.
Publicado: (2012)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

147. Defining the Optimal Serial Testing Interval and Features for Identifying Patients with Early SARS-CoV-2 Infection
por: Kanjilal, Sanjat
Publicado: (2021)

Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer
por: Lai, J, et al.
Publicado: (2003)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study
por: Hosein, AN, et al.
Publicado: (2012)

A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy
por: Liu, Chao, et al.
Publicado: (2014)

Expression profiling of nasal polyp epithelial cells identifies two distinct phenotypes and suggests a role for neurogenic inflammation
por: Cornet, Marjolein, et al.
Publicado: (2015)

Defining difficult public health facilities
por: Baruah, Jhimly, et al.
Publicado: (2012)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Integrated virus-host methylome analysis in head and neck squamous cell carcinoma
por: Wilson, Gareth A, et al.
Publicado: (2013)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

Research impact: defining it, measuring it, maximising it, questioning it
por: Greenhalgh, Trisha
Publicado: (2014)

Sepsis Endotypes Defined By Cytokine Trajectory Analysis
por: Zhu, L, et al.
Publicado: (2015)

Breast interventional devices: how they evolve and define new subspecialities
por: Burbank, F
Publicado: (2006)

Premalignancy in the human breast: how is it defined, is morphology good enough?
por: Gusterson, BA
Publicado: (2003)

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)
por: Bruyand, M, et al.
Publicado: (2009)

Lineage-Specific Methyltransferases Define the Methylome of the Globally Disseminated Escherichia coli ST131 Clone
por: Forde, Brian M., et al.
Publicado: (2015)

Defining standards for modelling the biomechanics of the foot and ankle: a systematic review
por: Bishop, Chris, et al.
Publicado: (2011)

Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease
por: Buckley, C, et al.
Publicado: (2005)

Is it possible to define a best practice standard for coercive treatment in psychiatry?
por: Sartorius, Norman
Publicado: (2007)

Using discrete choice experiments to define patient preferences for outcomes in trials
por: Fargher, Emily, et al.
Publicado: (2013)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

64. DEFINING THE IDEAL MALE BUTTOCKS: A CROWDSOURCING ANALYSIS OF IDEAL DIMENSIONS
por: Kollu, Tejas, et al.
Publicado: (2022)

Comparative analysis of human mitochondrial methylome show distinct patterns of epigenetic regulation in mitochondria
por: Ghosh, Sourav, et al.
Publicado: (2014)

Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice
por: Haney, Staci L., et al.
Publicado: (2016)

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
por: Chen, Sujun, et al.
Publicado: (2022)

Distinctive personality patterns in patients with chronic viral hepatitis
por: Cercel, Ioana-Catrinel, et al.
Publicado: (2014)

The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
por: Phillips, Patrick PJ, et al.
Publicado: (2011)

OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract
por: Carias, AM, et al.
Publicado: (2009)

Defining recovery from anorexia nervosa: a Delphi study to explore practitioners' views
por: Dawson, Lisa, et al.
Publicado: (2013)

Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.
por: Chenevix-Trench, G., et al.
Publicado: (1989)

Antimicrobial peptides: Defending the mucosal epithelial barrier
por: Johnstone, Karen F., et al.
Publicado: (2022)

Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer
por: Lewis, Aaron G, et al.
Publicado: (2005)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
por: Mina, Rina, et al.
Publicado: (2011)

Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance
por: Wainberg, Mark A
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_saj1f0qloba629krr778a8c6o3